[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370075-105":59,"doc-detail-370075-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","hpv-driven-inflammatory-pathways-in-ovarian-carcinogenesis-molecular-mechanisms-and-emerging-therapeutic-interventions","HPV-driven inflammatory pathways in ovarian carcinogenesis - molecular mechanismsand emerging therapeutic interventions","","Ovarian cancer is driven by persistent inflammation and reduced response to standard therapies, with high-risk human papillomavirus (HR-HPV) implicated in disease development. This narrative review links HPV infection to molecular and immune pathways, focusing on E6/E7 effects on p53 and pRb, and activation of NF-κB/STAT3 inflammatory signaling. It also covers disruption of innate antiviral defenses, hormonal amplification of viral activity, and therapeutic opportunities targeting inflammation, STING signaling, immune checkpoints, and hormone modulation.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hpv-driven-inflammatory-pathways-in-ovarian-carcinogenesis-molecular-mechanisms-and-emerging-therapeutic-interventions/370075/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hpv-driven-inflammatory-pathways-in-ovarian-carcinogenesis-molecular-mechanisms-and-emerging-therapeutic-interventions/370075.png","ImageObject",300,407,{"name":92,"@type":93},"anakgang17","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"What therapeutic intervention directions are proposed to interrupt the viral–inflammatory cycle?","Question",{"text":112,"@type":113},"The review suggests targeted strategies such as cytokine inhibitors and STING activators, combined with immune checkpoint therapy. It also includes hormone-modulating agents aimed at reducing proinflammatory amplification in ovarian tissues.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},370075,1790217987,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":131,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":132,"faqs":133,"seo_title":134,"seo_description":67,"update_tm":135,"read_time":136,"preview_page_count":19,"preview_urls":137},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Kermanshahi etal. Journal of Ovarian Research (2026) 19:24 Journal of Ovarian Research  \n[https://doi.org/10.1186/s13048-025-01948-0](https://doi.org/10.1186/s13048-025-01948-0)  \nREVIEW Open Access  \nHPV-driven inflammatory pathways in ovarian  carcinogenesis: molecular mechanismsand emerging therapeutic interventions  \nAtefeh Zamani Kermanshahi 1,2, Fatemeh Ebrahimi3, Ahmad Taherpoor4, El ham Kamal Kazemi5, Javid Sadri Nahand 1,2, Vahdat Poortahmasebi 1,2, Abolfazl Jafari-Sales 1,6,7 and Hossein Bannazadeh Baghi 1,2,7*  \nAbstract  \nOvarian cancer, an aggressive gynecological tumor, is primarily driven by persistent inflammation and resistance to conventional treatments. High-risk human papillomavirus (HR-HPV) has been identified as a potential contributing factor to disease development. In this narrative review, we integrate current findings on how HPV infection intersects with molecular and immune pathways in OC. The viral oncoproteins E6 and E7 dismantle key tumor suppressors such as p53 and retinoblastoma protein (pRb), while simultaneously activating inflammatory circuits like NF-κB and STAT3, resulting in continuous cytokine release and immune dysfunction. HPV also interferes  \nwith innate antiviral defenses, including Toll-like receptor and cGAS–STING pathways, thereby evading immune clearance. In parallel, hormonal regulators such as estrogen further enhance viral activity and amplify proinflammatory signaling within ovarian tissues. We argue that HPV-driven inflammation represents a significant but understudied mechanism in ovarian tumor biology. Recognizing this relationship provides new opportunities for therapeutic innovation. Targeted interventions ranging from cytokine inhibitors and STING activators to immune checkpoint therapy and hormone-modulating agents offer promising strategies to interrupt the viral–inflammatory cycle that sustains tumor progression. Ultimately, HPV may not serve as a primary cause of ovarian cancer, but it likely functions as a powerful enhancer of inflammation and oncogenic signaling. Clarifying this contribution reshapes our understanding of ovarian carcinogenesis and points toward novel translational approaches for prevention and treatment.  \nKeywords Ovarian cancer, HPV, Inflammation, Tumor microenvironment, Targeted therapy  \n*Correspondence:  \nHossein Bannazadeh Baghi  \n[hbannazadeh@tbzmed.ac.ir](hbannazadeh@tbzmed.ac.ir); [hb.zadeh@gmail.com](hb.zadeh@gmail.com)  \n1Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz 5166/15731, Iran  \n2Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran  \n3Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran  \n4Department of Clinical Bacteriology, Virology, Faculty of Medicine and Anti-microbial Research Center, Mashhad University of Medical Sciences, Mashhad, Iran  \n5Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran 6Department of Microbiology, Kaz. C., Islamic Azad University, Kazerun, Iran  \n7Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative","cbCaidalajtfXl0c","https://ap.wps.com/l/cbCaidalajtfXl0c","pdf",2450258,"English","# Abstract\n# Introduction","[{\"question\":\"What therapeutic intervention directions are proposed to interrupt the viral–inflammatory cycle?\",\"answer\":\"The review suggests targeted strategies such as cytokine inhibitors and STING activators, combined with immune checkpoint therapy. It also includes hormone-modulating agents aimed at reducing proinflammatory amplification in ovarian tissues.\"}]","HPV-driven inflammatory pathways in ovarian carcinogenesis - molecular mechanismsand emerging therapeutic interventions | PDF",1790186595,76,[138,142,146,150],{"page_no":8,"url":139,"width":140,"height":141},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e10b696623ebae14c0e6c181541bf0df.webp",983,1310,{"page_no":14,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5aa0a12d2714046498de42abde2f969.webp",982,1309,{"page_no":81,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f20fe7be5e71a3bc827708992d9645af.webp",981,1308,{"page_no":19,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41bec7cd2e91895e86c7cad895746050.webp",980,1306]